Drug Manufacturers

Drug manufacturers do as the name suggests; they develop and make drugs for the healthcare industry.

Drug manufacturers create industrial-scale pharmaceutical drugs for distribution by medical practitioners, pharmacies and hospitals. To create these medicines, drug manufacturers have operations of separate units including milling, granulation, coating, tablet pressing, and others.

Examples of companies in this sector include FibroGen, Neos Therapeutics, and Diplomat Pharmacy.

Sorrento Therapeutics Higher on Bullish Reports

Jan 22 Siraj Sarwar

Sorrento Therapeutics (NASDAQ:SRNE) shares are rallying over the last three months, thanks to the company’s smart business strategies and advancements in its pipeline. Its shares spiked more than 20% in Monday trade and its volume ... [Read]

Why is Innovus Pharmaceuticals Trading Up Nearly 30% Today?

Jan 18 Caroline Harris

As we move closer to the end of the month, with only two and half weeks left, it’s safe to say that the month of January has proven to be very beneficial for Innovus Pharmaceuticals ... [Read]

Sucampo Pharmaceuticals Shares have 157% Upside

Jan 17 Siraj Sarwar

Sucampo Pharmaceuticals (NASDAQ:SCMP) stock price rallied sharply in the last three months, surging more than 74%. Despite the recent rally, Sucampo Pharmaceuticals’ stock has strong upside potential, supported by its improving financial numbers and the ... [Read]

Aradigm Corporation Dropped More Than 30% Today, Here’s Why

Jan 9 Caroline Harris

Regardless of whether or not you are an Aradigm Corporation (NASDAQ:ARDM) shareholder, it is crucial that the entire marketplace becomes aware of the latest news surrounding the Hayward, California-based specialty pharmaceutical company. What’s Happened? Despite ... [Read]

Agile Therapeutics Denied Approval By FDA for Contraceptive Patch, But the Problem May Be With the FDA, Not the Patch

Dec 22 Samara Malkin

Agile Therapeutics, Inc. (NASDAQ:AGRX) took a nasty blow today when it announced that the FDA would not be approving Agile’s contraceptive patch Twirla. This is, in fact, the second time that Twirla has been denied ... [Read]

Hydropothecary Acquires Additional 78 Acres, On Track for Expansions

Dec 12 Samara Malkin

The Hydropothecary Corp. (TSXV:THCX) is making progress on its plans for expansion. The company has just recently acquired 78 acres, in addition to its already-owned 65-acre facility. With this additional land, Hydropothecary is on track ... [Read]

Impax Laboratories Receives Tentative Approval for Generic Coreg CR Extended-Release Capsules

Dec 8 Samara Malkin

Impax Laboratories, Inc. (NASDAQ:IPXL) has received tentative US FDA approval on its Abbreviated New Drug Application. The application was for a generic form of Coreg CR (carvedilol phosphate) extended-release capsules, in quantities of 10, 20, ... [Read]

Impax Laboratories Being Investigated For Merger with Amneal Pharmaceuticals

Dec 7 Samara Malkin

The Impax Laboratories (NASDAQ:IPXL) Board of Directors is being investigated by the stock legal firm Brower Piven in regards to its impending merger with Amneal Pharmaceuticals. Brower Piven is looking into prospective breaches of fiduciary ... [Read]

Hydropothecary Creates Stock Option Grants for Directors and Officers

Dec 5 Samara Malkin

The Hydropothecary Corp. (TSXV:THCX) has made stock option grants available to its directors and officers. Under its stock option plan, the grant is to acquire a total of 1.75 million common shares of the company. There ... [Read]

Hydropothecary Awarded with Best New Cannabis Product for Decarb and Elixir Strains

Dec 1 Samara Malkin

The Hydropothecary Corp. (TSXV:THCX) was awarded the Best New Cannabis Product at the inaugural annual Canadian Cannabis Awards gala. Two of Hydropothecary’s products received this recognition. Decarb, the company’s ready-to-consume activated and edible cannabis powder, ... [Read]